Skip to main content
. 2023 Jan 3;78(4):418–421. doi: 10.1136/thorax-2022-219378

Figure 1.

Figure 1

Clinical, quality of life and imaging measurements at baseline (7±4 months since PCR test) and follow-up (14±4 months since PCR test). (A) shows tabulated baseline and follow-up measurements. (B) provides spaghetti plots for DLCO, SGRQ score, 129Xe MRI RBC:TP and RBC:gas measurements at baseline and follow-up. Differences were analysed for significance using paired t-tests. *n=20. 6MWD, 6 min walk distance; DLCO, diffusing capacity of the lung for carbon monoxide; FEV1, forced expiratory volume in 1 s; %pred, per cent of predicted value; FVC, forced vital capacity; FeNO, fractional exhaled nitric oxide; mBDS, modified Borg Dyspnoea Scale; RBC, red blood cell; SGRQ, St. George’s Respiratory Questionnaire; TP, tissue plasma.